Multidisciplinary Advances in Cancer Care—Innovations in Early Detection, Precision Medicine, and AI Driven Strategies
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 31 July 2026 | Viewed by 21
Special Issue Editors
Interests: advancing early detection; precision medicine; AI-driven strategies across multiple cancer types, including lung cancer, cervical cancer, colorectal cancer, and brain tumors; multi-cancer early detection (MCED) platforms
Interests: photodynamic therapy (PDT)
Interests: mechanistic studies of photodynamic therapy for in vitro and in vivo cancer models; method development of miRNA profiling using NGS; AI development for cancer characterization and classification on histopathological slides
Special Issue Information
Dear Colleagues,
Cancer remains a leading global health challenge, with lung cancer, cervical cancer, colorectal cancer, and brain tumors among the most prevalent and deadly. Recent breakthroughs in early detection, precision therapeutics, and AI enabled diagnostics are transforming care across these tumor types. This Special Issue aims to showcase cutting edge research and expert perspectives that accelerate translation from bench to bedside and improve patient outcomes worldwide.
We invite submissions that address innovative approaches to screening, molecularly guided therapies, immuno-oncology, tumor microenvironment biology, and AI/radiomics integration, as well as studies focused on risk stratification and equity in cancer care.
Topics of Interest
- Early Detection & Screening
- Liquid biopsy and multi‑cancer early detection (MCED) platforms
- Imaging innovations for lung, cervical, colorectal, and brain cancers
- AI‑powered risk prediction and screening optimization
- Precision Medicine & Targeted Therapies
- Molecular profiling and targeted treatments across cancer types
- Combination strategies and resistance mechanisms
- Antibody‑drug conjugates and novel therapeutic targets
- Advancement in Radiotherapy, Chemotherapy and others
- Immunotherapy & Tumor Microenvironment
- Biomarkers predicting response across solid tumors
- Stromal and immune cell interactions as therapeutic targets
- Novel checkpoint inhibitors and combination regimens
- Radiomics & AI Integration
- Prognostic and predictive models using imaging and omics
Dr. Eva Y W Cheung
Dr. Ricky Wu
Prof. Dr. Ellie S.M. Chu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer early detection
- multi-cancer screening
- liquid biopsy
- cancer biomarkers
- tumor imaging and prognostics radiomics and artificial intelligence
- precision oncology
- targeted therapies
- immunotherapy and tumor microenvironment
- cancer prevention
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
